Biomedical Sciences and Translational Medicine MRes
Programme duration: Full-time: 12 months
Programme start: September 2022
Entry requirements: Applicants should have a good first degree in a relevant subject (2:1 Hons or higher). Applicants with a high 2:2 (55% and above) will be considered on a case by case basis. Please see the Entry requirements tab for further information.
This twelve month, full-time programme is structured to allow for 3 hours of taught sessions per week whilst the rest of the time is spent in the lab or carrying out other research project related work.
MRes in Biomedical Sciences and Translational Medicine students undertake 1 research project over 36 weeks including 2 weeks set aside for preparation of a preliminary project report and 4 weeks dedicated to writing the final research project report and preparing oral, poster and digital media presentations. During the project, all students are encouraged to suggest experiments, design experimental protocols, as well as being taught subject specific techniques and advanced knowledge and transferable skills. The research projects will include a range of research techniques to enhance training in experimental skills.
Lectures on taught modules relate to state-of-the-art research techniques, application of knowledge in areas of modern biomedical and translational research, and the development of personal and professional transferable skills. Important and innovative parts of our transferable skills training include workshops on "IP and Commercialisation (our own version of Dragon’s Den)", and “Grant Writing”, as well as debates and approaches to improve public understanding of science.
Why Institute of Systems, Molecular and Integrative Biology?
Our departments are equipped with the expertise and technology to carry out groundbreaking research, which informs our study programmes.
Our current key areas of research include:
The biology and chemistry of life at all scales
Cellular signalling mechanisms in normal and abnormal conditions
Improving the efficacy, safety and understanding of therapeutics in human disease
Advancing the molecular understanding of cancer to increase early detection and improve treatment for cancer patients.
Our collaboration with North West Cancer Research and Clatterbridge Cancer Centre is the first time we're integrating discovery sciences with oncology in one research centre. Working across basic and clinical sciences will not only improve our understanding of cancer but also develop new therapies to put into practice in clinics.